<DOC>
	<DOCNO>NCT02214550</DOCNO>
	<brief_summary>The purpose study determine woman dysmenorrhea ( painful period ) high future risk develop chronic pelvic pain ( CPP ) oral contraceptive ( OC ) use reverse chronic pain risk . Investigators examine whether dysmenorrhea produce CPP via repetitive cross organ sensitization ( COS ) episodes . The use cyclical OCs eliminate dysmenorrhea expect reduce COS decrease risk develop CPP .</brief_summary>
	<brief_title>Chronic Pain Risk Associated With Menstrual Period Pain</brief_title>
	<detailed_description>Endometrial shed menstrual cycle elicit profound change neuronal activity cytokine produce moderate severe pelvic pain 20 % reproductive-age woman . One every five woman turn develop chronic pelvic pain ( CPP ) , yet woman without dysmenorrhea rarely report CPP . CPP disorder irritable bowel syndrome ( IBS ) painful bladder syndrome ( PBS ) cause severe , unrelenting pain due lack effective treatment . This study consist 2 aim . Aim # 1 : To determine dysmenorrhea concomitant bladder pain sensitivity exhibit neurophysiological feature consistent establish CPP . Women chronic pain dysmenorrhea without COS use control . Quantitative sensory testing ( QST ) noninvasive bladder pain test investigator validate previously use determine whether impairment descend inhibition pelvic sensitivity responsible vulnerability COS woman dysmenorrhea . EEG record look difference brain activity response sensory stimulation participant cohort . Aim # 2 : To differentiate individual contribution circulate sex hormone repeat sensitize event ( painful menses ) descend peripheral mechanism bladder pain . The QST/bladder pain measure study Aim # 1 retested within dysmenorrhea+COS group follow one-year randomized trial cyclical OCs vs. continuous OCs vs. treatment . An observational arm PBS participant receive continuous OCs serve control .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<mesh_term>Migraine Disorders</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<mesh_term>Cystitis</mesh_term>
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Visceral Pain</mesh_term>
	<mesh_term>Cystitis , Interstitial</mesh_term>
	<criteria>All Reproductive age woman ( 1845 ) For dysmenorrhea D+COS group : Participants must regular ( 2245 day ) menstrual cycle least two month period precede test All presence active pelvic abdominal malignancy ( primary metastatic ) active genitourinary infection last four week unable read comprehend inform consent English unwilling undergo pelvic examination/testing presence hypertension risk develop hypertension , For dysmenorrhea D+COS group : absence regular menses ( include current pregnancy , recent pregnancy , active breast feeding ) unwilling take either cyclic combine OCs unwilling withdraw OCs two month prior Aim # 1 study visit .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Cystitis , Interstitial</keyword>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Migraine Disorders</keyword>
	<keyword>Cross Organ Sensitization</keyword>
	<keyword>Pelvic Pain</keyword>
	<keyword>Endometriosis</keyword>
	<keyword>Contraceptives , Oral</keyword>
	<keyword>Birth Control Pills</keyword>
	<keyword>Painful Bladder Syndrome</keyword>
	<keyword>Visceral Pain</keyword>
	<keyword>Chronic Pain</keyword>
</DOC>